The goal of bioprinting healthy, functional organs is driven by the need for organ transplants
Scientists have 3D-printed exquisitely entangled vascular networks that mimic the body’s natural passageways for blood, air and other vital fluids, an advance that may pave the way for developing functional artificial organs. For the study, published in the journal Science, researchers 3D-printed a proof-of-principle—a hydrogel model of a lung-mimicking air sac in which airways deliver oxygen to surrounding blood vessels.
“One of the biggest road blocks to generating functional tissue replacements has been our inability to print the complex vasculature that can supply nutrients to densely populated tissues,” said Jordan Miller, assistant professor at Rice University in the US.
“Further, our organs actually contain independent vascular networks—like the airways and blood vessels of the lung or the bile ducts and blood vessels in the liver,” Miller said.
“These interpenetrating networks are physically and biochemically entangled, and the architecture itself is intimately related to tissue function. Ours is the first bioprinting technology that addresses the challenge of multivascularisation in a direct and comprehensive way,” he said.
Kelly Stevens, assistant professor at University of Washington (UW) in the US, said multivascularisation is important because form and function often go hand in hand.
The goal of bioprinting healthy, functional organs is driven by the need for organ transplants.
Thousands of people are on transplant waiting lists across the world, and those who do eventually receive donor organs still face a lifetime of immune-suppressing drugs to prevent organ rejection.
Bioprinting has attracted intense interest over the past decade because it could theoretically address both problems by allowing doctors to print replacement organs from a patient’s own cells.
A ready supply of functional organs could one day be deployed to treat millions of patients worldwide.
“We envision bioprinting becoming a major component of medicine within the next two decades,” Miller said.
“The liver is especially interesting because it performs a mind-boggling 500 functions, likely second only to the brain,” Stevens said.
“The liver’s complexity means there is currently no machine or therapy that can replace all its functions when it fails. Bioprinted human organs might someday supply that therapy,” he said.
To address this challenge, the team created a new open-source bioprinting technology dubbed the “stereolithography apparatus for tissue engineering,” or SLATE.
The system uses additive manufacturing to make soft hydrogels one layer at a time.
Layers are printed from a liquid pre-hydrogel solution that becomes a solid when exposed to blue light. A digital light processing projector shines light from below, displaying sequential 2D slices of the structure at high resolution, with pixel sizes ranging from 10-50 microns.
With each layer solidified in turn, an overhead arm raises the growing 3D gel just enough to expose liquid to the next image from the projector.
Tests of the lung-mimicking structure showed that the tissues were sturdy enough to avoid bursting during blood flow and pulsatile "breathing," a rhythmic intake and outflow of air that simulated the pressures and frequencies of human breathing.
Tests found that red blood cells could take up oxygen as they flowed through a network of blood vessels surrounding the "breathing" air sac.
This movement of oxygen is similar to the gas exchange that occurs in the lung's alveolar air sacs.
In the tests of therapeutic implants for liver disease, the team 3D printed tissues, loaded them with primary liver cells and implanted them into mice.
The tissues had separate compartments for blood vessels and liver cells and were implanted in mice with chronic liver injury. Tests showed that the liver cells survived the implantation.